Innovating Works

CONSERVAS EL CIDACOS

Active
ALPACA: ALgorithms for PAngenome Computational Analysis CONSERVAS EL CIDACOS participó en un H2020: H2020-MSCA-ITN-2020 Genomes are strings over the letters A,C,G,T, which represent nucleotides, the building blocks of DNA. In view of ultra-large amounts of gen...
2020-08-27 - 2024-12-31 | financed
YIELDGAP: YIELD stress fluids beyond Bingham closing the GAP in modelling real world yield stress materials CONSERVAS EL CIDACOS participó en un H2020: H2020-MSCA-ITN-2020 Industries based on yield-stress fluids are rapidly expanding in Europe, including key traditional sectors (food, building, paper) and key e...
2020-08-19 - 2024-12-31 | financed
FluxWIN: The role of non growing season processes in the methane and nitrous oxide budgets in pristine northe... CONSERVAS EL CIDACOS participó en un H2020: ERC-2019-STG The response of the terrestrial biosphere to climate change is still largely unknown and represents a key uncertainty in climate change pred...
2020-01-13 - 2025-03-31 | financed
REFOCUS: Chip Scale Self Referenced Optical Frequency Comb Sources CONSERVAS EL CIDACOS participó en un H2020: ERC-2019-STG As a Nobel-honored technology, optical frequency combs, which consist of equidistant spectral lines, have revolutionized applications in tim...
2019-10-02 - 2024-12-31 | financed
HERA: Integrating Environment and Health Research a Vision for the EU CONSERVAS EL CIDACOS participó en un H2020: H2020-SC1-BHC-2018-2020 Environmental degradation and pollution, climate change, and the destabilization of the ecosystem biodiversity, damage health and quality of...
2018-12-10 - 2022-03-31 | financed
SUMMIT: Stepping Up mRNA Mutanome Immunotherapy CONSERVAS EL CIDACOS participó en un H2020: ERC-2017-ADG Immunotherapy is expected to fundamentally change the treatment of cancer patients. Personalized vaccines eliciting immune responses against...
2018-07-11 - 2023-07-31 | financed
TNT-TUMORS: Therapeutic approaches to enhance innate immunity against Tumors CONSERVAS EL CIDACOS participó en un H2020: ERC-2015-AdG Recent advances using immune checkpoint inhibitors demonstrate the great potential of immunemodulation in cancer and metastasis treatment. H...
2016-07-27 - 2022-08-31 | financed
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.